Literature DB >> 4795621

The reaction of zymosan with the properdin system in normal and C4-deficienct guinea pig serum. Demonstration of C3- and C5-cleaving multi-unit enzymes, both containing factor B, and acceleration of their formation by the classical complement pathway.

V Brade, G D Lee, A Nicholson, H S Shin, M M Mayer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4795621

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  24 in total

1.  Binding of the complement intermediate C56 to zymosan in acute phase human sera.

Authors:  P J Baker; L G Rubin; T F Lint; B C McLeod; H Gewurz
Journal:  Clin Exp Immunol       Date:  1975-04       Impact factor: 4.330

2.  The effect of anticomplementary substances on properdin in normal and C2-deficient sera.

Authors:  R H McLean; K Townsend; A F Michael
Journal:  Clin Exp Immunol       Date:  1975-03       Impact factor: 4.330

3.  Complement activation by the alternative pathway and macrophage enzyme secretion in the pathogenesis of chronic inflammation.

Authors:  H U Schorlemmer; D Bitter-Suermann; A C Allison
Journal:  Immunology       Date:  1977-06       Impact factor: 7.397

4.  C3 proactivator (C3PA) as an acute phase reactant.

Authors:  M Schutte; R DiCamelli; P Murphy; M Sadove; H Gewurz
Journal:  Clin Exp Immunol       Date:  1974-10       Impact factor: 4.330

5.  Interaction of complex polysaccharides with the complement system: effect of calcium depletion on terminal component consumption.

Authors:  R Snyderman; M C Pike
Journal:  Infect Immun       Date:  1975-02       Impact factor: 3.441

6.  Solid phase activation of alternative pathway of complement by beta-1,3-glucans and its possible role for tumour regressing activity.

Authors:  J Hamuro; U Hadding; D Bitter-Suermann
Journal:  Immunology       Date:  1978-04       Impact factor: 7.397

7.  Incompatibility between C3b and B of guinea-pig and man and its influence on the titration of the alternative pathway factors D and B in these two species.

Authors:  V Brade; L Dieminger; G Schmidt; W Vogt
Journal:  Immunology       Date:  1976-02       Impact factor: 7.397

8.  Dichotomy between opsonization and serum complement activation by encapsulated staphylococci.

Authors:  P K Peterson; Y Kim; B J Wilkinson; D Schmeling; A F Michael; P G Quie
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

9.  The conversion of human complement component C5 into fragment C5b by the alternative-pathway C5 convertase.

Authors:  R G DiScipio
Journal:  Biochem J       Date:  1981-12-01       Impact factor: 3.857

10.  Studies on the possible involvement of complement component C3 in the initiation of acid hydrolase secretion by macrophages. I. Correlation between enzyme-releasing and complement-activating capacities of several secretagogues.

Authors:  D W Riches; D R Stanworth
Journal:  Immunology       Date:  1981-09       Impact factor: 7.397
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.